Id2 GABAergic interneurons comprise a neglected fourth major group of cortical inhibitory cells

  1. Robert Machold
  2. Shlomo Dellal
  3. Manuel Valero
  4. Hector Zurita
  5. Illya Kruglikov
  6. John Hongyu Meng
  7. Jessica L Hanson
  8. Yoshiko Hashikawa
  9. Benjamin Schuman
  10. György Buzsáki
  11. Bernardo Rudy  Is a corresponding author
  1. New York University, United States
  2. Hospital del Mar Medical Research Institute (IMIM), Spain
  3. University of Colorado Boulder, United States

Abstract

Cortical GABAergic interneurons (INs) represent a diverse population of mainly locally projecting cells that provide specialized forms of inhibition to pyramidal neurons and other INs. Most recent work on INs has focused on subtypes distinguished by expression of Parvalbumin (PV), Somatostatin (SST), or Vasoactive Intestinal Peptide (VIP). However, a fourth group that includes neurogliaform cells (NGFCs) has been less well characterized due to a lack of genetic tools. Here, we show that these INs can be accessed experimentally using intersectional genetics with the gene Id2. We find that outside of layer 1 (L1), the majority of Id2 INs are NGFCs that express high levels of neuropeptide Y (NPY) and exhibit a late-spiking firing pattern, with extensive local connectivity. While much sparser, non-NGFC Id2 INs had more variable properties, with most cells corresponding to a diverse group of INs that strongly expresses the neuropeptide CCK. In vivo, using silicon probe recordings, we observed several distinguishing aspects of NGFC activity, including a strong rebound in activity immediately following the cortical down state during NREM sleep. Our study provides insights into IN diversity and NGFC distribution and properties, and outlines an intersectional genetics approach for further study of this underappreciated group of INs.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files; Source Data files have been provided for Figures 1, 2, 4, Table 1, Figure 1 - figure supplement 1 and Figure 1 - figure supplement 2.

The following previously published data sets were used
    1. Yao et al.
    (2021) Whole Cortex and Hippocampus - 10x genomics (2020) with 10x-Smart-Seq Taxonomy
    https://portal.brain-map.org/atlases-and-data/rnaseq/mouse-whole-cortex-and-hippocampus-10x.

Article and author information

Author details

  1. Robert Machold

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6261-496X
  2. Shlomo Dellal

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Manuel Valero

    Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  4. Hector Zurita

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Illya Kruglikov

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. John Hongyu Meng

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jessica L Hanson

    Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Yoshiko Hashikawa

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Benjamin Schuman

    Neuroscience Institute, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. György Buzsáki

    Neuroscience Institute, Langone Medical Center, Department of Neurology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3100-4800
  11. Bernardo Rudy

    Neuroscience Institute, New York University, New York, United States
    For correspondence
    Bernardo.Rudy@nyulangone.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1367-7136

Funding

National Institutes of Health (P01NS074972)

  • Bernardo Rudy

National Institutes of Health (R01NS110079)

  • Bernardo Rudy

National Institutes of Health (U19NS107616)

  • György Buzsáki

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experimental animals were handled with care to minimize suffering in accordance with institutional animal care and use committee (IACUC) protocols approved by the Division of Comparative Medicine at the NYU Langone Medical Center for Dr. Bernardo Rudy's lab (#IA15-01465 and #IA15-01473).

Copyright

© 2023, Machold et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,690
    views
  • 271
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Robert Machold
  2. Shlomo Dellal
  3. Manuel Valero
  4. Hector Zurita
  5. Illya Kruglikov
  6. John Hongyu Meng
  7. Jessica L Hanson
  8. Yoshiko Hashikawa
  9. Benjamin Schuman
  10. György Buzsáki
  11. Bernardo Rudy
(2023)
Id2 GABAergic interneurons comprise a neglected fourth major group of cortical inhibitory cells
eLife 12:e85893.
https://doi.org/10.7554/eLife.85893

Share this article

https://doi.org/10.7554/eLife.85893

Further reading

    1. Neuroscience
    Jian Dong, Mian Chen ... Matthijs Verhage
    Research Article

    Dense core vesicles (DCVs) transport and release various neuropeptides and neurotrophins that control diverse brain functions, but the DCV secretory pathway remains poorly understood. Here, we tested a prediction emerging from invertebrate studies about the crucial role of the intracellular trafficking GTPase Rab10, by assessing DCV exocytosis at single-cell resolution upon acute Rab10 depletion in mature mouse hippocampal neurons, to circumvent potential confounding effects of Rab10’s established role in neurite outgrowth. We observed a significant inhibition of DCV exocytosis in Rab10-depleted neurons, whereas synaptic vesicle exocytosis was unaffected. However, rather than a direct involvement in DCV trafficking, this effect was attributed to two ER-dependent processes, ER-regulated intracellular Ca2+ dynamics, and protein synthesis. Gene Ontology analysis of differentially expressed proteins upon Rab10 depletion identified substantial alterations in synaptic and ER/ribosomal proteins, including the Ca2+ pump SERCA2. In addition, ER morphology and dynamics were altered, ER Ca2+ levels were depleted, and Ca2+ homeostasis was impaired in Rab10-depleted neurons. However, Ca2+ entry using a Ca2+ ionophore still triggered less DCV exocytosis. Instead, leucine supplementation, which enhances protein synthesis, largely rescued DCV exocytosis deficiency. We conclude that Rab10 is required for neuropeptide release by maintaining Ca2+ dynamics and regulating protein synthesis. Furthermore, DCV exocytosis appeared more dependent on (acute) protein synthesis than synaptic vesicle exocytosis.

    1. Neuroscience
    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.